Difference between revisions of "Dalteparin (Fragmin)"
Jump to navigation
Jump to search
m (Text replace - "or the prescribing information<ref name="insert"></ref>." to "or the prescribing information.<ref name="insert"></ref>") |
(updated content) |
||
| Line 2: | Line 2: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Low molecular weight heparin, binds to antithrombin III, accelerating its activity and inhibiting factor Xa and thrombin.<ref name="insert">[http:// | + | Class/mechanism: Low molecular weight heparin, binds to antithrombin III, accelerating its activity and inhibiting factor Xa and thrombin.<ref name="insert">[http://us.eisai.com/package_inserts/Fragmin_PI.pdf Dalteparin (Fragmin) package insert]</ref><ref>[[Media:Dalteparin.pdf | Dalteparin (Fragmin) package insert (locally hosted backup)]]</ref><ref>[http://us.eisai.com/product.asp?ID=236 Fragmin manufacturer's website]</ref> |
<br>Route: SC | <br>Route: SC | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
| Line 9: | Line 9: | ||
==Patient drug information== | ==Patient drug information== | ||
| + | *Brief patient counseling information can be found on [http://us.eisai.com/package_inserts/Fragmin_PI.pdf#page=17 page 17 of the Dalteparin (Fragmin) package insert]<ref name="insert"></ref> | ||
*[http://www.uptodate.com/contents/dalteparin-patient-drug-information Dalteparin (Fragmin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/dalteparin-patient-drug-information Dalteparin (Fragmin) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/dalteparin-patient-drug-information Dalteparin (Fragmin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/dalteparin-patient-drug-information Dalteparin (Fragmin) patient drug information (UpToDate)]</ref> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Hematology medications]] | ||
| + | [[Category:Hemostasis medications]] | ||
| + | [[Category:Heparins]] | ||
| + | [[Category:Low molecular weight heparins]] | ||
Revision as of 06:05, 14 October 2012
Also known as LMWH.
General information
Class/mechanism: Low molecular weight heparin, binds to antithrombin III, accelerating its activity and inhibiting factor Xa and thrombin.[1][2][3]
Route: SC
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Brief patient counseling information can be found on page 17 of the Dalteparin (Fragmin) package insert[1]
- Dalteparin (Fragmin) patient drug information (UpToDate)[4]